Health care stocks were declining late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.5%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, Upexi (UPXI) shares soared 152% after the company said it was investigating an instance of possible stock manipulation.
Avalon GloboCare (ALBT) shares jumped past 10% after saying Friday it signed a memorandum of understanding with Qi Diagnostics for the planned co-development of a cannabis breathalyzer.
HCA Healthcare (HCA) shares tumbled 9%. The company's Q3 results missed analyst estimates as Hurricane Helene impacted some of its facilities, while the hospital operator expects a further hurricane-related hit in the ongoing three-month period.
ImmunityBio (IBRX) shares surged 28% after the company reported late Thursday dosing of the first patients in a phase 1 trial that will assess its CAR-NK cellular therapy as a potential treatment for non-Hodgkin's lymphoma.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。